why choose us

First received: December 07, 2022

Clinical Trial: Artificial Pancreas Technology to Reduce Glycemic Variability and Improve Cardiovascular Health in Type 1 Diabetes

Study Status: Completed

Recruit Status: RECRUITING

Condition: Type 1 Diabetes

Study Type: INTERVENTIONAL


Official Title: Using Closed-Loop Artificial Pancreas Technology to Reduce Glycemic Variability and Subsequently Improve Cardiovascular Health in Type 1 Diabetes

Brief Summary: This study will examine the potential cardiovascular effect(s) of artificial pancreas (AP) technology in patients with type 1 diabetes.AP technology is a system of devices that closely mimics the glucose-regulating function of a healthy human pancreas.It includes an insulin pump and a continuous glucose monitor (CGM).In this study, the investigators will research whether improvements in blood glucose levels and blood glucose variability will in turn decrease biomarkers of inflammation and endothelial dysfunction…

Read more